In an effort to support global initiatives to contain the spread of the new coronavirus (COVID-19), the Academy is presenting Spring 2020 events through online platforms and some of our previously scheduled events are being postponed to a later date. Please check our events listing for the latest information and contact our Customer Service team with any additional questions. For Academy programs and resources about COVID-19, click here.

We are experiencing intermittent technical difficulties. At this time, you may not be able to log in, register for an event, or make a donation via the website. We appreciate your patience, and apologize for any inconvenience this may cause.

This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

Annals

Skeletal Biology and Medicine, Part B

Edited by Edited by Mone Zaidi (Mount Sinai School of Medicine, New York, New York)
Skeletal Biology and Medicine, Part B

Published: November 2007

Volume 1117

Learn More

The second of two volumes, this volume comprises three sections: new insights on the interaction of blood vessels and bone, particularly the role of angiogenic signals and hypoxia in osteogenesis and bone repair, as well as the dysregulation of transcription factors causing arterial calcification; a new theme—integrating the evolving role of immune cells, infection, and inflammation in causing bone loss seen, for example, in various forms of arthritides; and the clinical and therapeutic challenges in bone, stone, and joint diseases, and areas such as identification of high-risk patients, advent of novel therapeutic targets, genetic aberrations causing bone disease, and issues surrounding bone loss in malignancy, hyperparathyroidism, and adrenal disorders.